← All trials
NCT03850067
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 12, 2019
- Primary completion
- Dec 2, 2019
- Completion date
- Mar 20, 2022
- First posted
- —
- Last posted
- —
- Enrollment
- 18
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- CelgeneLead sponsor
- CelgeneStudy director
- University of ValenciaOverall official - principal investigator
- Marche Polytechnic UniversityOverall official - principal investigator
- Vita-Salute University of Milano. ItalyOverall official - principal investigator
- Institut Gustave RoussyOverall official - principal investigator
- University of BolognaOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.